AI Article Synopsis
- The study aimed to create practical guidelines for managing pancreatolithiasis, as new procedures besides surgery are emerging.
- Three committees were formed, including endoscopists and a surgeon, to develop clinical questions and statements from a review of 694 published studies.
- The resulting clinical guidelines for pancreatolithiasis were validated through a modified Delphi method, but further discussions for international guidelines are necessary.
Article Abstract
Objectives: In addition to surgery, procedures for patients with pancreatolithiasis are developing; therefore, establishing practical guidelines for the management of pancreatolithiasis is required.
Methods: Three committees (the professional committee for asking clinical questions (CQs) and statements by Japanese endoscopists, the expert panel committee for rating statements by the modified Delphi method, and the evaluating committee by moderators) were organized. Eight endoscopists and a surgeon for pancreatolithiasis made the CQs and statements from a total of 694 reports of published literature by PubMed search (from 1983 to 2012). The expert panelists individually rated these clinical statements using a modified Delphi approach, in which a clinical statement receiving a median score greater than 7 on a 9-point scale from the panel was regarded as valid.
Results: The professional committee made 3, 7, and 10 CQs and statements for the concept and pathogenesis, diagnosis, and treatment, respectively. The expert panelists regarded them as valid after a 2-round modified Delphi approach.
Conclusions: After evaluation by the moderators, the Japanese clinical guidelines for pancreatolithiasis were established. Further discussions and studies for international guidelines are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MPA.0000000000000449 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities.
Int J Hematol
January 2025
Associated Department With Mie Graduate School of Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan.
This study discusses disseminated intravascular coagulation (DIC) associated with solid cancers and various vascular abnormalities, both of which generally exhibit chronic DIC patterns. Solid cancers are among the most significant underlying diseases that induce DIC. However, the severity, bleeding tendency, and progression of DIC vary considerably depending on the type and stage of the cancer, making generalization difficult.
View Article and Find Full Text PDFArticle Synopsis
- Congenital cytomegalovirus (cCMV) infection is the most prevalent congenital infection in developed nations, and while there’s no established standard therapy yet, management evidence is growing.
- The first edition of the "Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection" was published in Japan in 2023, outlining key clinical questions related to cCMV.
- The guidelines cover 20 clinical questions on aspects like prenatal risk assessment, diagnosis, treatment, and follow-up, along with recommendations and consensus rates to aid healthcare providers in managing cCMV patients.
Japanese clinical practice guidelines for prostate cancer 2023.
Int J Urol
November 2024
Department of Urology, Wakayama Medical University, Wakayama, Japan.
Article Synopsis
- - This fourth edition of the Japanese Clinical Practice Guidelines for Prostate Cancer 2023 was developed by the Japanese Urological Association and involved experts from various related organizations, ensuring a comprehensive approach to prostate cancer management.
- - The guidelines emphasize the use of systematic reviews to inform recommendations for 14 specific clinical questions, with decisions made based on the collective input of 24 guideline development members.
- - A general statement outlines findings from literature searches on areas not covered by systematic reviews, with a focus on updates and changes since the last guidelines published in 2016.
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol
August 2024
Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan.
Article Synopsis
- G-CSF is a supportive treatment used to prevent severe complications from chemotherapy in patients with non-round cell soft tissue sarcomas (NRC-STS), with two key clinical questions raised about its effectiveness.
- A literature review found a limited number of studies that addressed these questions, resulting in only a few articles being included for analysis.
- The conclusion suggests that there is insufficient scientific evidence to confirm the benefits of G-CSF prophylaxis in improving treatment outcomes for NRC-STS, indicating the need for further research.
Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6.
Acta Biomater
January 2023
Molecular Pharmacy Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. Electronic address:
Article Synopsis
- The use of biomaterials in medicine has improved drug delivery and decreased complications in procedures like transplantations and hemodialysis, but immune reactions remain a challenge.
- Factor H (FH), a protein that regulates the complement system and dampens immune responses, can be recruited to biomedical surfaces using a cyclic peptide called 5C6, which helps reduce immune activation.
- This research identifies the key structural elements of 5C6 necessary for effective binding to FH, enhancing its potential application as a therapeutic tool to minimize complement activation on biomaterials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!